Not all countries have the same organizational models, but the payment system between the government and hospitals seems to be a determining factor for the health policy evaluation.
It is necessary to rethink how are paid the radiotherapy costs Read More »
Older adults who are overweight or obese who stick most closely to the Mediterranean diet preserve their cognitive performance and even improve their abilities after three years
The Mediterranean diet helps improve cognitive function and memory Read More »
The Generalitat of Catalonia has awarded IDIBELL a co-financed project of 2 million euros that will consolidate Personalized Medicine on the Bellvitge campus. The money will be used to create and improve infrastructures that allow the management and storage of patient samples and derived data, ensuring their integrity and traceability.
IDIBELL receives a grant from the Generalitat to promote Personalized Medicine on campus Read More »
A study led by IDIBELL and the ICO has analyzed genetic data from thousands of patients with inflammatory bowel disease through an innovative statistical approach that has made it possible to identify new susceptibility genes to this disease.
Identified new susceptibility genes to inflammatory bowel diseases Read More »
A team from IDIBELL and the University of Barcelona has devised two treatments based on this innovative technology: a derivative of morphine that does not generate addition, a new treatment against psoriasis. Also they used this technology to determine the adenosine role in pain transmission.
Light-activated drugs, localized medicine without side effects Read More »
Cystinuria is a rare disease characterized by the formation of cystine stones in the kidney and urinary tract. This compound could prevent or delay the appearance of cystine stones.
A natural compound designated as an orphan drug for cystinuria Read More »
The study shows that one-year survival after transplantation is greater than 80% regardless of whether there was telomere dysfunction.
Lung transplantation is effective for pulmonary fibrosis patients with short telomeres Read More »
The results of a study carried out by Dr. Mónica Povedano, principal investigator at IDIBELL, reinforce the value of centralized care for the disease
Multidisciplinary care increases the quality of life and survival of ALS patients Read More »
M. Carolina Florian, head of the Stem Cell Aging group, to present new research in the biology of aging at the world’s largest aging research for drug discovery conference
Aging of the hematopoietic stem cell niche Read More »
The study has identified mutations of this gene in ten families and biochemical studies in the laboratory have confirmed that these variants are responsible for the symptoms. Possible treatments have already been tested through massive drug analyzes, which will then be tested in mini-brains generated from cells of the patients.
IDIBELL scientists identify the PI4KA gene as the cause of a new neurological disease Read More »
